07 Jan 2001

Thiogamma® 200 (Thiogamma® 200 oral/-300 oral Kapseln) - Deutschland

Updated: 07 Jan 2001

Thiogamma® 200 oral | -300 oral; -600 oral; -300 Injekt N | -600 Injekt | -TurboInjekt | -TurboInjekt Pur

Mißempfindungen bei diabetischer Polyneuropathie.

Thiogamma® 200 Description, Presentation and Dosage

Thiogamma® 200 Description

Thiogamma® 200 Drug Class Description

alpha-Liponsäure

Thiogamma® 200 Drug Description

1 Kps. enth.: 'alpha'-Liponsäure 200 mg/300 mg.

Thiogamma® 200 Generic Name

Thiogamma® 200 oral/-300 oral Kapseln

Thiogamma® 200 Presentation

Thiogamma® 200 Presentation

Thiogamma® 200 oral/-300 oral; -600 oral; -300 Injekt N/ -600 Injekt/-TurboInjekt/-TurboInjekt Pur

Thiogamma® 200 Manufacturer

Wörwag

Related Learning Zones

CLL Knowledge Centre and CME

CLL Knowledge Centre and CME

The Chronic Lymphocytic Leukaemia (CLL) Knowledge Centre contains useful information arranged within four main sections: ‘Disease Awareness’, ‘Events’, ‘Resources’, and 'CME'. Healthcare professionals will find information on pathophysiology, signs and symptoms of CLL, diagnosis, prognosis, treatment and management options, an upcoming events calendar and an external links listing,

The CME activity ‘Treatment Optimisation in Chronic Lymphocytic Leukaemia’ has been EACCME-accredited and awarded 1 CME credit. Test your knowledge by answering quiz questions based on patient case study scenarios.

Cystic Fibrosis Knowledge Centre

Cystic Fibrosis Knowledge Centre

Cystic fibrosis (CF) is a genetic condition caused by a defect in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel. The Cystic Fibrosis Knowledge Centre provides healthcare professionals with access to disease awareness information, emerging and established treatment options and current best practice based on recently updated guidelines by the European Cystic Fibrosis Society (ECFS). A resources section contains external links to upcoming medical conferences and patient support groups.

This resource is developed by EPG Health Media for epgonline.org, supported by an independent educational grant from Vertex.

Thiogamma® 200 Dosage

Thiogamma® 200 Adult Dosage

Glycerol, Sorbitol, Hartfett, Farbstoffe E 171, E 104, 200 oral zusätzl.: E 124, 300 oral zusätzl.: E 172.

Thiogamma® 200 Child Dosage


Thiogamma® 600 oral Filmtabletten
Zus.: 1 Filmtbl. enth.: 'alpha'-Liponsäure 600 mg.
Weit. Bestandteile: Hypromellose, Carmellose-Natrium, Dimeticon, Magnesiumstearat, Macrogol, Talkum, Natriumdodecylsulfat, Lactose.

Thiogamma® 300 Injekt N/-600 Injekt Injektionslösung
Zus.: 1 Amp. (10 ml/20 ml) enth.: 'alpha'-Liponsäure, Megluminsalz 583,85 mg/1167,70 mg (entspr. 300 mg/600 mg 'alpha'-Liponsäure).
Weit. Bestandteile: Meglumin, Macrogol 300, Wasser f. Inj.-zwecke.

Thiogamma® TurboInjekt/-Pur Injektionslösung
Zus.: 1 Inj.fl. (50 ml) enth.: 'alpha'-Liponsäure, Megluminsalz 1167,7 mg (entspr. 600 mg 'alpha'-Liponsäure).
Weit. Bestandteile: Meglumin, Macrogol, Wasser f. Inj.-zwecke.

Thiogamma® 200 Precautions, Reactions and Contraindications

Thiogamma® 200 Special Precautions

Thiogamma® 200 Special Precautions

L 42

Thiogamma® 200 Adverse Reactions

Thiogamma® 200 Adverse Reactions

L 42

Related Drugs - Pain Management

Back to top